Key result
Preventive anticoagulation with 40 mg daily of Enoxaparin in 65 adult patients with nephrotic syndrome resulted in no observed thrombotic events and a low incidence of bleeding.
Why the study?
Does enoxaparin prevent thrombotic complications in adult patients with nephrotic syndrome?
Population
65 adult patients with nephrotic syndrome.
Design
Cohort
Follow-up
Up to 48 months
Authors
Loading...
May support enoxaparin prophylaxis in nephrotic syndrome; leaves open confirmation in randomized trials.
Cohort (n=65)
Does enoxaparin prevent thrombotic complications in adult patients with nephrotic syndrome?
Enoxaparin 40 mg daily appears safe, effective, and well-tolerated for the prevention of thrombotic complications in adult patients with nephrotic syndrome.
Rostoker et al. (2008) conducted a cohort in Nephrotic syndrome (n=65). Enoxaparin was evaluated on Thrombosis and side effects. Preventive anticoagulation with 40 mg daily of Enoxaparin in 65 adult patients with nephrotic syndrome resulted in no observed thrombotic events and a low incidence of bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: